Clinical Trials for Age-Related Muscle Atrophy

Home
About Us
- Mission
- Technology
- Leadership
- FAQs
Overview
News
Contact

✕

Home
Pipeline

Pipeline

Recent News

Mar 4, 2025
Immunis Treats its First Patients for Sarcopenic Obesity
Jan 11, 2025
Immunis Closes $25 Million Series A-1 Financing Round
Nov 19, 2024
Immunis Successfully Completes its Phase 1/2a Clinical Trial Targeting Muscle Atrophy

Navigation

Home
About Us
- Mission
- Technology
- Leadership
- FAQs
Overview
News
Contact

Contact info

Immunis, Inc.
Irvine, California

contact@immunisbiomedical.com

© 2023 Immunis, Inc. | All Rights Reserved